Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Bausch Health Companies Inc (NYSE: BHC) closed the day trading at $7.3 down -2.54% from the previous closing price of $7.49. In other words, the price has decreased by -$2.54 from its previous closing price. On the day, 1.98 million shares were traded. BHC stock price reached its highest trading level at $7.55 during the session, while it also had its lowest trading level at $7.25.
Ratios:
For a better understanding of BHC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.55. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.
On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8. Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 21 ’25 when Lee Frank D. sold 15,912 shares for $7.66 per share. The transaction valued at 121,886 led to the insider holds 73,795 shares of the business.
Lee Frank D. bought 15,912 shares of BHC for $121,888 on Aug 21 ’25. On Aug 14 ’25, another insider, Paulson John, who serves as the Director of the company, bought 34,721,118 shares for $9.00 each. As a result, the insider paid 312,490,062 and bolstered with 70,755,869 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2761100800 and an Enterprise Value of 23623317504. As of this moment, Bausch’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.87, and their Forward P/E ratio for the next fiscal year is 1.76. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 15.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27. Its current Enterprise Value per Revenue stands at 2.396 whereas that against EBITDA is 7.596.
Stock Price History:
The Beta on a monthly basis for BHC is 0.48, which has changed by 0.22483218 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, BHC has reached a high of $9.85, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is 10.46%, while the 200-Day Moving Average is calculated to be 9.66%.
Shares Statistics:
Over the past 3-months, BHC traded about 2.87M shares per day on average, while over the past 10 days, BHC traded about 6677070 shares per day. A total of 369.75M shares are outstanding, with a floating share count of 326.88M. Insiders hold about 11.60% of the company’s shares, while institutions hold 67.65% stake in the company. Shares short for BHC as of 1753920000 were 7286725 with a Short Ratio of 2.54, compared to 1751241600 on 8323683. Therefore, it implies a Short% of Shares Outstanding of 7286725 and a Short% of Float of 2.1300000999999997.
